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Enzyme Commission number (6.1.1.19)Arginyl-tRNA synthetase (ArgRS) is a tRNA-binding protein that catalyzes the esteriﬁcation of L-argi-
nine to its cognate tRNA. L-Canavanine, a structural analog of L-arginine, has recently been studied
as an anticancer agent. Here, we determined the crystal structures of the apo, L-arginine-complexed,
and L-canavanine-complexed forms of the cytoplasmic free isoform of human ArgRS (hArgRS). Sim-
ilar interactions were formed upon binding to L-canavanine or L-arginine, but the interaction
between Tyr312 and the oxygen of the oxyguanidino group was a little bit different. Detailed con-
formational changes that occur upon substrate binding were explained. The hArgRS structure was
also compared with previously reported homologue structures. The results presented here may pro-
vide a basis for the design of new anticancer drugs, such as L-canavanine analogs.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Aminoacyl-tRNA synthetases (aaRSs) catalyze the esteriﬁcation
of amino acids to their cognate tRNAs during protein synthesis [1].
In the two-step reaction, aminoacyl adenylate formation occurs in
the presence of amino acids, ATP and Mg2+, and then the aminoacyl
group of the enzyme-bound intermediate is transferred to the 30-
end of the cognate tRNA to form an aminoacyl-tRNA [2]. The 20
aaRSs are divided into two groups based on characteristic con-
served structural regions in their active site [2]; class I aaRSs con-
tain ‘HIGH’ and ‘KMSKS’ motifs in the Rossmann fold, whereas class
II aaRSs have three homolog motifs in the catalytic domain [2].
The class I arginyl-tRNA synthetase (ArgRS) localizes to the
cytoplasm. In contrast to that of other organisms, mammalian
cytoplasmic ArgRS exists as two isoforms that are generated from
different translational initiations of the same mRNA. Two isoforms
of ArgRS participate in protein synthesis and the N-end rule path-
way of protein degradation with similar catalytic characteristics,
respectively [3–9]. Like glutamyl- and glutaminyl-tRNA syntheta-ses, they also require the presence of cognate tRNA for amino acid
activation [4,10–12]. During protein translation, one ArgRS iso-
form, a component of the multi-synthetase complex, interacts with
several proteins, such as the tRNA-associating factor p43 and leu-
cyl-tRNA synthetase, through its 72 amino acid N-terminal exten-
sion [6,13–15]. The second isoform, which lacks the N-terminal
extension and exists as a free protein [5], is thought to play a role
in the N-end rule pathway of ubiquitin-dependent protein degra-
dation by participating in the formation and provision of Arg-
tRNAArg to arginyl-tRNA transferase for arginylation of all acidic
N-terminal residue, as well as oxidized cysteine [3,4,7,16].L-Cana-
vanine, which was originally isolated from jack bean plant (Cana-
valia ensiformis), is an ArgRS substrate that can be incorporated
as a structural analog of L-arginine [17,18]. L-Canavanine has an
oxyguanidino group, in which the methylene group of arginine is
replaced with an oxygen atom; hence, L-canavanine is slightly
longer and less basic than L-arginine [19]. Recently, L-canavanine
has been investigated as an anticancer agent because it is toxic
to cancer cells and is particularly effective against the growth of
pancreatic cancer cells [19,20]. Binding of L-canavanine into ArgRS
may lead to the synthesis of proteins with abnormal functions or
defective structures [21], and the disruption of protein degradation
by the N-end rule pathway [3,7,19]. Determination of the structure
of the ArgRS–L-canavanine complex would shed light on the mech-
anism by which this substrate is recognized.
Here, we determined the crystal structures of the free isoform
of Homo sapiens ArgRS (hArgRS), including the apo form and the
Table 1
Data collection, phasing, and reﬁnement statistics.
Apo L-Arginine L-Canavanine
Data collection
Wavelength (Å) 0.9800 0.9794 0.9870
Space group P212121 P212121 P212121
Cell dimensions
a, b, c (Å) 77.62, 105.23,
172.25
74.49, 106.90,
175.25
75.39,
109.31,
175.01
Resolution (Å)a 50.00–2.80
(2.85–2.80)
50.00–2.40
(2.44–2.40)
30–2.80
(2.85–2.80)
Reﬂections (Total/
Unique)
194070/33971 263322/55170 190567/
35623
Redundancy 5.7 (3.4) 4.8 (3.2) 5.3 (3.4)
Completeness (%) 95.5 (89.1) 97.8 (95.4) 97.8 (95.7)
I/r (I) 19.51 (3.78) 27.5 (3.04) 17.11 (2.85)
Rmerge 0.086 (0.314) 0.075 (0.306) 0.103 (0.313)
Reﬁnement
Resolution (Å) 45–2.8 40–2.4 30–2.8
No. reﬂections 33922 55082 35509
Rwork/Rfree (%) 20.81/26.78 19.62/25.37 20.51/26.23
No. atoms
(Protein/Water/
Ligand/Glycerol)
9162/171 9478/275/24/
28
9349/205/24
Average B factors
(Protein/Water/
Ligand/Glycerol (Å2))
47.50/36.01 47.50/46.4/
43.32/48.34
42.00/32.12/
21.14
RMSD
Bonds (Å) 0.010 0.009 0.009
Angles () 1.384 1.111 1.219
Ramachandran plot (%)
Favored regions 90.09 95.56 90.47
Allowed regions 8.66 3.67 8.74
Outlier regions 1.25 0.77 0.79
a The resolution range at the outer shell is shown in parenthesis.
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yses conﬁrmed that L-canavanine can be incorporated into the
active site of hArgRS in place of L-arginine. The mechanism of L-
canavanine recognition and orientation in the active site, and the
interactions of residues in hArgRS with L-canavanine and L-argi-
nine, are discussed. The conformational changes that occur upon
binding to the substrate are also explained. Furthermore, based
on structural superimpositions onto reported structures, the pre-
dicted interactions of each domain of hArgRS with tRNAArg are
discussed.
2. Materials and methods
2.1. Protein expression and puriﬁcation
The gene encoding the cytoplasmic form of ArgRS lacking the 72
amino acid N-terminal region was ampliﬁed from H. sapiens geno-
mic DNA by polymerase chain reaction and cloned into the pET28a
vector (Novagen) at the NheI and NotI sites. The recombinant
pET28a plasmid was transformed into Escherichia coli Rosetta
(DE3) cells (Novagen), which were grown at 37 C in Luria broth
containing 100 lg/ml kanamycin until they reached an OD600 of
0.6. Overexpression of hArgRS was induced by incubation with
1 mM isopropyl-b-D-1-thiogalactopyranoside at 18 C for 16 h.
The cells were harvested by centrifugation at 4000g for 25 min,
resuspended in buffer A (30 mM Tris–HCl, pH 8.0, and 150 mM
NaCl) containing 1 mM phenylmethylsulfonyl ﬂuoride, and then
disrupted by sonication. The supernatant was obtained by centrifu-
gation at 25000g for 45 min, loaded onto a HiTrap™ column (GE
Healthcare), and then washed with buffer A containing 20 mM
imidazole. The hArgRS protein was eluted using the linear gradient
method with buffer A containing 20–500 mM imidazole. After dial-
ysis of the eluted protein against buffer B (30 mM Tris–HCl, pH
8.0), the protein was loaded onto a HiTrap™ Q HP column (GE
Healthcare), which had been equilibrated with buffer B, and then
eluted with a linear gradient of 0–1 M NaCl. Finally, the eluted pro-
tein was applied to a HiLoad 26/60 Superdex™ 200 column (Amer-
sham), which had been equilibrated with buffer C (30 mM Tris–
HCl, pH 8.0, and 100 mM NaCl). The highly puriﬁed protein
(>95%) was obtained about 7.5 mg from a 4-L cell culture using
E. coli expression and then concentrated to about 25 mg/ml for
crystallization.
2.2. Crystallization and structure determination
Initial screening for hArgRS was performed with a screening kit
for crystallization (Hampton Research). Single crystals were
obtained using the hanging drop vapor diffusion method by mixing
1 ll of the protein with 1 ll of reservoir solution (0.085 mM
sodium citrate tribasic dehydrate (pH 5.7), 24% polyethylene glycol
4000, 0.17 M ammonium acetate, and 15% glycerol) for 2–3 days at
22 C. To obtain the crystals complexed with L-arginine or L-cana-
vanine, puriﬁed hArgRS was incubated for 2 h on ice with 1 mM
L-arginine (Sigma) or L-canavanine (Sigma), respectively. The crys-
tals were frozen in liquid nitrogen and X-ray diffraction data were
collected using beamline BL1A at the Photon Factory, Japan. The
data were integrated and scaled using the HKL2000 package [22].
The structure of Saccharomyces cerevisiae ArgRS (Protein Data Bank
(PDB) entry: 1BS2) was modiﬁed using the PHENIX program sculp-
tor [23] followed by a search model for molecular replacement
with AutoMR. The structures of the apo and substrate-bound hAr-
gRS complexes were reﬁned with PHENIX [23] and manually built
using the COOT application [24]. The reﬁned structures that were
validated by the MOLPROBITY program [25] are summarized in
Table 1. The crystallographic data for apo, L-arginine complexed,and L-canavanine complexed hArgRS have been deposited in the
PDB under IDs 4Q2Y, 4Q2T, and 4Q2X, respectively.
3. Results and discussion
3.1. Overall structure of hArgRS
The crystal structures of the apo, L-arginine complexed, and L-
canavanine complexed forms of the free isoform of hArgRS were
determined. Each crystal belonged to space group P212121 and con-
tained two molecules in the asymmetric unit. Analysis of the
hArgRS crystals using the program PISA [26] showed that the sur-
face of the dimer was 1153.2 Å2, and the gel ﬁltration showed
hArgRS exists as a monomer in solution, which suggests the dimer
was induced by crystal packing. Analysis of the crystal structures
revealed that hArgRS comprises ﬁve domains: an N-terminal
domain (Nd) that includes residues 1–119; a catalytic domain,
insertion domains 1 (Ins1) and 2 (Ins2) that are located at the N-
and C-terminal ends of the catalytic domain, respectively; and a
C-terminal domain (Cd) that includes residues 383–588 (Fig. 1A).
The Nd, which is organized into four a-helices and an anti-parallel
b-sheet containing four strands, is linked to the catalytic domain
by a long loop. The catalytic domain is composed of two assembly
regions and forms the Rossmann fold. The ﬁrst region includes res-
idues 230–260 and 120–170, and harbors the ‘HIGH’ motif (His136,
Val137, Gly138, and His139). The second region includes residues
312–382. Ins1 comprises three a-helices and is located between
the separated parts of the ﬁrst region of the catalytic domain, while
Ins2 contains a three-stranded anti-parallel b-sheet and connects
the second region of the catalytic domain to the Cd. The Cd, which
includes a bundle of eight a-helices (a13–a20), is situated next to
Fig. 1. (A) The overall structure of the cytoplasmic free form of hArgRS bound to L-arginine. The Nd, catalytic domain, Ins1, Ins2, and Cd are shown in blue, gray, green, pink,
and yellow, respectively. L-Arginine is shown in magenta. (B) Magniﬁed views of the substrates in the active site pocket are shown as electrostatic surface models. L-Arginine,
glycerol, and L-canavanine are shown as magenta, wheat, and yellow stick models, respectively. The chemical structures of L-arginine and L-canavanine are shown above the
images. (C, D) Magniﬁed views of the binding sites in hArgRS for L-arginine and glycerol (C), and L-canavanine (D). L-Arginine, glycerol, and L-canavanine are colored as
described for (B). The residues interacting with the substrates are depicted by stick models and the water molecules are shown as red spheres. Hydrogen bonds are indicated
by black dotted lines. The omit map calculated around L-arginine and L-canavanine (shown in cyan and yellow, respectively) represents 2.0 r. (E) Superimposition of the
interactions in the binding sites for L-arginine and L-canavanine in hArgRS. L-Arginine and L-canavanine are colored as described for (B). Interactions between hArgRS and L-
arginine or L-canavanine are indicated as gray or dark gray stick models, respectively.
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the Nd (Fig. 1A).
3.2. The L-canavanine recognition site
To conﬁrm that L-canavanine can be incorporated into hArgRS
in place of L-arginine, we determined the structure of the
hArgRS-L-canavanine complex with 2.8 Å resolution. L-Canavanine
bound to the solvent-accessible active site of hArgRS, which is
organized by the C-terminal region of the Rossmann fold
(Fig. 1B). The structural analysis revealed that L-canavanine is ori-
entated with the oxyguanidino moiety docked inside the nega-
tively charged pocket, and the carboxyl and amino groups of the
substrate are positioned at the entrance of the active site pocket(Fig. 1B). The residues preceding the a5 and a11 helices and the
b5 strand participate in substrate recognition (Fig. 1A). The oxy-
guanidino moiety of L-canavanine forms a hydrogen bond with
Tyr312 and salt bridges with the carboxylates of Asp125 and
Asp316 (Fig. 1D). The carboxyl group of the substrate forms hydro-
gen bonds with the side chains of Asn130, Gln340, and His139. In
addition, the nitrogen atom of the substrate’s amino group is
hydrogen-bonded to the side chain of Asn130 and the main chain
of Ser128, and indirectly to the carboxylate of Asp337 via a water
molecule. The oxygen of the substrate’s oxyguanidino group forms
a hydrogen bond with Tyr312. With the exception of Asp125,
which is replaced with glutamate, these residues are conserved
among different organisms (S. cerevisiae, Pyrococcus horikoshii,
and Thermus thermophilus) (Fig. 4). In addition to Tyr132, two
Fig. 2. (A–C) Structural comparisons of the apo (A), L-canavanine-complexed (B), and L-arginine-complexed (C) forms of hArgRS shown as electrostatic surface models. The
residues that form hydrogen bonds are indicated by stick models and water molecules are shown as red spheres. Hydrogen bonds are indicated by black dotted lines. The
active site pocket for the substrate and the cavity for binding of the tRNAArg acceptor arm are represented by yellow and green dotted circles, respectively. (D) A structural
superimposition of the apo (cyan), L-canavanine-complexed (pink), and L-arginine-complexed (gray) forms of hArgRS. Each structure is shown as a ribbon model. The large
and small boxed areas, which are markedly different regions, indicate those shown in (A–C) and (E), respectively. The disordered regions are indicated by dotted lines. (E)
Comparisons of residues in the active sites. The shifted residues are shown as stick models, which are colored as in (D). The directions of their shift are indicated by arrows.
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roles in substrate distinction.
3.3. The L-arginine recognition site
Next, we determined the structure of the hArgRS-L-arginine
complex at 2.4 Å resolution (Fig. 1A). Both L-arginine and glycerol
bound to the active site pocket, and the recognition and orientation
of L-arginine at this site were similar to those of S. cerevisiae ArgRS
[27,28] and the hArgRS-L-canavanine complex (Fig. 1B). The struc-
tural analysis revealed that the nitrogen atom of L-arginine inter-
acts directly with Ser128 and Asn130 and indirectly with the
side chain of Glu263 through Wat6 (Fig. 1C). The L-arginine car-
boxyl group forms hydrogen bonds with Asn130, His139, andGln340. In addition, the negatively charged residues, Asp125 and
Asp316, interact with the substrate’s guanidino group, as well as
Tyr312.
Glycerol bound to the active site pocket located between the C-
terminus of the b11 strand and the N-terminus of the a5 helix
(Fig. 1A and B). It interacted with the side chain of Ser142 and
the main chains of Asp337 (Fig. 1C). Notably, glycerol was situated
in the ATP-analog binding region corresponding to that of P. hori-
koshii ArgRS [29]. The interaction between glycerol and Ser142
mimics the hydrogen bond formed between the 30-carbon of an
ATP-analog pentose sugar and Asn141 via a water molecule in P.
horikoshii ArgRS. The interaction of Asp337 with glycerol also mim-
ics the interaction between the 2´-carbon of an ATP-analog pentose
sugar and the main chain of Gly384. Although these results
Fig. 3. A structural superimposition of hArgRS and S. cerevisiae ArgRS bound to
tRNAArg with L-arginine [28]. The hArgRS domains are colored as described for
Fig. 1A. S. cerevisiae ArgRS is shown as a pale cyan ribbon model. The structural
inserted regions and the X loop of hArgRS are indicated in magenta and orange,
respectively.
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pocket is too small. Consequently, conformational changes of the
loop between the b5 strand and the a5 helix, and the N-terminus
of the a5 helix containing the ‘HIGH’ motif, are required for ATP
binding. The derived size of the ATP binding pocket in the presence
of arginine gives a molecular basis as to why tRNA is required for
arginine activation [28].
3.4. Comparisons of the L-canavanine and L-arginine binding sites
The interactions between the active site of hArgRS and L-cana-
vanine were similar to those between the active site and L-arginine.
However, the interaction between Tyr312 and the oxygen of the
oxyguanidino group differed between these complexes (Fig. 1D).
Tyr312 pulls the oxyguanidino group, twisting L-canavanine, which
is slightly longer than L-arginine, and causing Asp316 to interact
with the oxyguanidino group (Fig. 1D and E). Tyr312 is essential
for the stable binding of L-canavanine. Compared with hArgRS–L-
canavanine, the positions of two residues, namely Asp337 and
Asp316, were shifted in hArgRS–L-arginine (Fig. 1E). In hArgRS–L-
canavanine, Asp337 interacts with the carboxyl group of the sub-
strate via Wat50. This residue is not conserved among other organ-
isms and the interaction was not observed in hArgRS–L-arginine or
S. cerevisiae ArgRS-L-arginine. This interaction may stabilize bind-
ing of the carboxyl group of L-canavanine to Asn130, His139, and
Gln340 of hArgRS.
3.5. Structural conformational changes
Previous reports of the structure of ArgRS discussed the confor-
mational changes that occur upon binding to tRNAArg with and
without L-arginine, as well as an ATP analog [27–29]. Here, to pro-
vide insight into the conformational changes that occur during rec-
ognition of L-canavanine and L-arginine in the absence of tRNAArg,
the structures of the apo, L-canavanine-complexed, and L-argi-
nine-complexed forms of hArgRS were compared (Fig. 2A–E). The
loops in the Nd between the a2 helix and the b1 strand, and
between the a2 and a3 helices, were disordered in the apo struc-ture (Fig. 2D). The analysis revealed that, in the absence of the sub-
strate, the active site pocket is maintained in an open state by
Asn130, Glu263, and Tyr312 (Fig. 2A). By interacting with the side
chain of Gln172 in the a6 helix of Ins1 via Wat25, Tyr312 is posi-
tioned close to Ins1, and Gln172 forms two hydrogen bonds with
the side chains of Asn130 and Tyr201. The side-chain carboxyl
group of Glu263 also interacts with the main chain of Trp169.
These interactions generate the open substrate-accessible pocket.
The active site residues, Asn130, Tyr312, Asp316, and Gln340, shift
to recognize the substrate (Fig. 2B, C and E). In particular, Asn130,
Tyr312, and Gln340 are associated with the closed form of the
active site pocket, as well as several other residues. Asn130 shifts
to form hydrogen bonds with the carboxyl and amino groups of
the substrate, and Gln340 shifts to interact with its carboxyl group.
Tyr312 and Asp316 move towards the oxyguanidino group of L-
canavanine and the guanidinium group of L-arginine (Fig. 2B and
C). In addition, Glu263 shifts to interact with the side chain of
Ser315. Shifting of Glu263 and Tyr312 are essential for creating
the closed form of the active site pocket and preventing access
by another substrate. Therefore, shifting of the active site and sur-
rounding residues, especially Asn130 and Tyr312, are required for
formation of the active site pocket and substrate recognition.
Shifting of Tyr312 and Glu263 forms a cavity that is accessed by
the acceptor arm of tRNAArg (Fig. 2B and C). Comparison of the
structures of tRNAArg-bound ArgRS from S. cerevisiae in the pres-
ence and absence of L-arginine revealed that Tyr347 is essential
for the correct localization of the CCA end of tRNAArg [28]. In the
absence of the substrate, this residue prevents proper positioning
of the CCA end of tRNAArg via interaction with the main chain of
Trp192, and in the presence of substrate, it generates the confor-
mational change necessary to stabilize the CCA end. By contrast,
the structural analysis described here revealed that, in the absence
of substrate, a tRNAArg acceptor arm-accessible cavity is not gener-
ated in hArgRS though indirect interactions of Tyr312 with Glu172
and Asn130 via Wat25, and interaction of the side chain of Glu263
with the main chain of Trp169 (Fig. 2A). In the presence of L-argi-
nine- or L-canavanine-, the shifted Tyr312 and Glu263 residues of
hArgRS, which interact with the substrate and Ser315, respectively,
form the tRNAArg acceptor arm-accessible cavity (Fig. 2B and C).
Glu263 in hArgRS corresponds to Glu294 in S. cerevisiae ArgRS
[28], which is an important residue for locking the 30-OH group
of the Ade76 residue of tRNAArg via a hydrogen bond. These results
suggest that, like L-arginine, binding of L-canavanine to the active
site of hArgRS gives rise to the formation of a pocket for binding
of the tRNAArg acceptor arm.
3.6. Comparisons with other structures
Although the sequence identities of ArgRSs from H. sapiens and
other organisms (S. cerevisiae, T. thermophilus, and P. horikoshii) are
considerably low (<25.9%), the overall structures are similar (Fig. 4
and Supplementary Fig. 1). The root mean square deviation (RMSD)
of the overall structures of hArgRS and S. cerevisiae ArgRS was
1.86 Å (calculated with 383 Ca atoms). The catalytic and Cd
domains of these proteins are also similar, with RMSDs of 0.75
and 0.83 Å (calculated with 111 and 123 Ca atoms), respectively.
However, the Nd, Ins1, and Ins2 are markedly different with
RMSDs of 7.09, 3.89, and 10.48 Å (calculated with 82, 38, and 30
Ca atoms), respectively (Supplementary Fig. 1). In the catalytic
domain, the substrate recognition sites and the ‘HIGH’ motif, in
which Ile is replaced with Val, are conserved, while the ‘KMSKS’
motif, which is located within the loop between Ins2 and Cd, is
not conserved and is structurally ﬂexible (Figs. 1A and 4).
The long loop in the Nd of hArgRS was not observed in the struc-
tures of the ArgRSs from P. horikoshii, T. thermophilus, or S. cerevisi-
ae (Supplementary Fig. 1). This loop contains an insertion
Fig. 4. Multiple sequence alignment of ArgRSs from H. sapiens (H_sa), S. cerevisiae (S_ce), T. thermophilus (T_th), and P. horikoshii (P_ho). The alignment was generated using
ESPrit [31]. Residues conserved across all four species are shaded red and residues conserved across three species are shown in red text. The secondary structure of hArgRS is
shown above the alignment and is colored as in Fig. 1A.
H.S. Kim et al. / FEBS Letters 588 (2014) 2328–2334 2333(Lys54–Val60) between the a2 and a3 helices (Fig. 3). Based on
structural superposition of hArgRS and S. cerevisiae ArgRS bound
to tRNAArg [28], the region is predicted to be involved in binding
and stabilization of the TwC loop of tRNAArg and may also stabilize
tRNAArg binding (Fig. 3). Furthermore, hArgRS has a long tRNAArg
anticodon-binding loop between the a19 and a20 helices in the
Cd; residues in this region that are involved in the recognition
and conformation of the tRNAArg anticodon loop (Tyr464, Arg468,
Arg474, Tyr540, Tyr544 and Met588) are highly conserved.
Trp569, which forms a stacking interaction between Ino34 and
Cyt35 of the tRNAArg anticodon in S. cerevisiae ArgRS, is replaced
with Tyr544 in hArgRS. The long anticodon tRNAArg-binding loop
contains a structurally inserted region (Lys548–Leu556) that is
thought to aid the interaction with and stabilization of the confor-
mation of the tRNAArg anticodon loop (Fig. 3). The characteristic X
loop, which is related to the correct location of the anticodon
through interaction with the major groove of the anticodon stem,
was also identiﬁed in hArgRS (Fig. 3). A protruding region compris-
ing six residues (Asp453–Thr458) between the a15 and a16 heli-
ces is not conserved; however, Gly456, which corresponds toGly483 in S. cerevisiae ArgRS that has a functional role in cell
growth, is conserved [30]. Gly483 plays a vital role for positioning
of the major groove of the anticodon stem because its mutation to
any other residue interferes with tRNAArg positioning [28].
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